檢索結果 - Underbayev, Chingiz
- Showing 1 - 14 results of 14
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL) 由 Kasar, Siddha, Underbayev, Chingiz, Hassan, Moinuddin, Ilev, Ilko, Degheidy, Heba, Bauer, Steven, Marti, Gerald, Lutz, Carol, Raveche, Elizabeth, Batish, Mona
出版 2016Text -
8
Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia 由 Underbayev, Chingiz, Kasar, Siddha, Ruezinsky, William, Degheidy, Heba, Schneider, Joel Solomon, Marti, Gerald, Bauer, Steven R., Fraidenraich, Diego, Lightfoote, Marilyn M., Parashar, Vijay, Raveche, Elizabeth, Batish, Mona
出版 2016Text -
9
A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era 由 Robinson, Hannah R., Qi, Junpeng, Cook, Erika M., Nichols, Cydney, Dadashian, Eman L., Underbayev, Chingiz, Herman, Sarah E. M., Saba, Nakhle S., Keyvanfar, Keyvan, Sun, Clare, Ahn, Inhye E., Baskar, Sivasubramanian, Rader, Christoph, Wiestner, Adrian
出版 2018Text -
10
MALT1 inhibition is efficacious in both naïve and ibrutinib-resistant chronic lymphocytic leukemia 由 Saba, Nakhle S., Wong, Deanna H., Tanios, Georges, Iyer, Jessica R., Lobelle-Rich, Patricia, Dadashian, Eman L., Liu, Delong, Fontan, Lorena, Flemington, Erik K., Nichols, Cydney M., Underbayev, Chingiz, Safah, Hana, Melnick, Ari, Wiestner, Adrian, Herman, Sarah E. M.
出版 2017Text -
11
Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma 由 Saba, Nakhle S., Liu, Delong, Herman, Sarah E. M., Underbayev, Chingiz, Tian, Xin, Behrend, David, Weniger, Marc A., Skarzynski, Martin, Gyamfi, Jennifer, Fontan, Lorena, Melnick, Ari, Grant, Cliona, Roschewski, Mark, Navarro, Alba, Beà, Sílvia, Pittaluga, Stefania, Dunleavy, Kieron, Wilson, Wyndham H., Wiestner, Adrian
出版 2016Text -
12
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia 由 Ahn, Inhye E., Underbayev, Chingiz, Albitar, Adam, Herman, Sarah E. M., Tian, Xin, Maric, Irina, Arthur, Diane C., Wake, Laura, Pittaluga, Stefania, Yuan, Constance M., Stetler-Stevenson, Maryalice, Soto, Susan, Valdez, Janet, Nierman, Pia, Lotter, Jennifer, Xi, Liqiang, Raffeld, Mark, Farooqui, Mohammed, Albitar, Maher, Wiestner, Adrian
出版 2017Text -
13
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy 由 Landau, Dan A., Sun, Clare, Rosebrock, Daniel, Herman, Sarah E. M., Fein, Joshua, Sivina, Mariela, Underbayev, Chingiz, Liu, Delong, Hoellenriegel, Julia, Ravichandran, Sarangan, Farooqui, Mohammed Z. H., Zhang, Wandi, Cibulskis, Carrie, Zviran, Asaf, Neuberg, Donna S., Livitz, Dimitri, Bozic, Ivana, Leshchiner, Ignaty, Getz, Gad, Burger, Jan A., Wiestner, Adrian, Wu, Catherine J.
出版 2017Text -
14
MARCKS affects cell motility and response to BTK inhibitors in CLL 由 Beckmann, Laura, Berg, Valeska, Dickhut, Clarissa, Sun, Clare, Merkel, Olaf, Bloehdorn, Johannes, Robrecht, Sandra, Seifert, Marc, da Palma Guerreiro, Alexandra, Claasen, Julia, Loroch, Stefan, Oliverio, Matteo, Underbayev, Chingiz, Vaughn, Lauren, Thomalla, Daniel, Hülsemann, Malte F., Tausch, Eugen, Fischer, Kirsten, Fink, Anna Maria, Eichhorst, Barbara, Sickmann, Albert, Wendtner, Clemens M., Stilgenbauer, Stephan, Hallek, Michael, Wiestner, Adrian, Zahedi, René P., Frenzel, Lukas P.
出版 2021Text